BBNX - Beta Bionics, Inc.
11.17
-0.260 -2.328%
Share volume: 799,855
Last Updated: 04-24-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$11.43
-0.26
-0.02%
Fundamental analysis
35%
Profitability
35%
Dept financing
22%
Liquidity
71%
Performance
30%
Performance
5 Days
-8.44%
1 Month
3.81%
3 Months
-25.18%
6 Months
-52.97%
1 Year
3.43%
2 Year
-52.73%
Key data
Stock price
$11.17
DAY RANGE
$10.82 - $11.60
52 WEEK RANGE
$8.80 - $32.71
52 WEEK CHANGE
$3.43
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
Company detail
CEO: Sean Saint
Region: US
Website: www.betabionics.com
Employees: 294
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: www.betabionics.com
Employees: 294
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. Our principal executive offices are located at 11 Hughes, Irvine, California.
Recent news